Interpretation of Microbiological Reports

Sample Integrity - Garbage In, Garbage Out

• Result accuracy depends critically on sample quality. "Garbage In, Garbage Out."
• Pre-analytical Errors → Misleading Results:
  • Improper Patient Prep: E.g., non-fasting, incorrect urine catch.
  • Faulty Collection: Non-aseptic, wrong site/timing, insufficient quantity.
  • Incorrect Container/Anticoagulant: E.g., wrong tube for blood, no preservative for urine if delayed.
    • Blood cultures: Use Sodium Polyanethol Sulfonate (SPS).
  • Mislabelling: Wrong patient ID, sample type, date/time.
  • Delayed/Improper Transport & Storage: Temperature critical.
• Consequences:
  • False positives (contamination).
  • False negatives (pathogen loss/inhibition).
  • Delayed/wrong diagnosis & treatment.

⭐ CSF transport: Bacterial suspected → Room Temperature. Viral suspected → Refrigerate (2-8°C) or freeze (≤ -70°C). Do NOT refrigerate CSF for bacterial culture.

Microscopy & Cultures - See, Grow, Identify

• Microscopy (Direct Exam): Rapid; guides empirical therapy.
  • Gram Stain: GPC (purple), GNB (pink/red); shape, arrangement. 📌 Purple Positive, Pink Negative.
  • ZN Stain: AFB (e.g., M. tuberculosis).
  • KOH Mount: Fungi. India Ink: Cryptococcus (capsules).
• Culture & Identification: Isolate, ID, quantify, AST.
  • Key Media:
    • Blood Agar (BA): Enriched; hemolysis (α, β, γ).
    • Chocolate Agar (CA): Fastidious (Haemophilus, Neisseria).
    • MacConkey Agar (MAC): GNB; Lactose Fermenters (LF) pink.
  • CFU Thresholds (UTI):
    • Clean catch: >10^5/mL. Catheter: >10^3/mL. Suprapubic: >10^2/mL.
• Interpreting Significance (e.g., Blood Culture):

⭐ Growth from normally sterile sites (CSF, blood, joint fluid) is ALWAYS significant.

Susceptibility & Special Tests - Drug Dilemmas Decoded

• MIC: Minimum Inhibitory Concentration. Defines Susceptible (S: treat), Intermediate (I: high dose/site-specific), Resistant (R: avoid) per CLSI/EUCAST.
• Methods: Kirby-Bauer (disk diffusion), Broth dilution, E-test.
  • 📌 SIR: Susceptible, Intermediate, Resistant.
• Key Resistance & Tests:
  • MRSA: Cefoxitin disk (≤21mm for S. aureus). mecA PCR for confirmation.
  • ESBL: Screen (↓ 3GCs). Confirm: Ceftazidime + Clavulanate (zone ↑ by ≥5mm).
  • CRE: Carbapenemase detection (e.g., mCIM, Carba NP). PCR for genes (KPC, NDM, OXA-48).
  • Inducible Clindamycin Resistance:

    ⭐ D-test: For Erythromycin-resistant Staphylococci. A flattened ("D" shape) clindamycin zone adjacent to an erythromycin disk indicates inducible resistance; clindamycin should be reported as resistant.

Clinical Detective Work - Connecting Lab & Clinic

• Crucial: Integrate lab findings with patient's clinical presentation for accurate diagnosis.
• Consider:
  • Pre-analytical variables: specimen quality, transport.
  • Patient factors: immune status, comorbidities, current therapy.
  • Organism: virulence, typical site.
• Distinguish:
  • Colonization vs. Infection.
  • Contamination vs. True pathogen.
• Effective clinician-laboratory communication is key.
• Blood Culture Interpretation Algorithm:

⭐ A rising antibody titer (e.g., 4-fold increase) between acute and convalescent sera is diagnostic for recent infection.

High‑Yield Points - ⚡ Biggest Takeaways

• Clinical correlation is key; treat the patient, not just the report.
• Differentiate true infection from colonization or contamination.
• Consider specimen source and quantity to distinguish pathogens from normal flora.
• AST results guide antibiotic choice; note resistance patterns.
• Immediately report critical results like positive blood/CSF cultures.
• Poor specimen quality (e.g., saliva in sputum) yields unreliable results.
• Beware of false positives (contamination) and false negatives (prior antibiotics).